• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期患者血浆D-二聚体变化的检测与研究

Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease.

作者信息

Liu B H, Sun M X, Zhou N, Li Y P, Wang M Z, Yu J, Zhou H S

机构信息

Respiratory Internal Medicine Department, Dongying People’s Hospital of Shandong provincial Hospital Group, Dongying, Shandong, China.

Tuberculosis Internal Medicine Department, Shandong Chest Hospital, Shangdong, China.

出版信息

J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):839-845.

PMID:27655508
Abstract

The purpose of this study was to observe the change in plasma D-dimer of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The patients were divided into three groups, i.e., AECOPD group, stable COPD group (COPD kept stable after treatment) and a healthy control group. The content of plasma fibrinogen (FIB) and D-dimer of all research subjects was detected and the difference between groups was analyzed. Moreover, pulmonary functions of patients in the AECOPD group and the stable COPD group, including forced expiratory volume in 1 second (FEV1%) and forced vital capacity rate of 1 second (FEV1/FVC), and blood gas (oxygen partial pressure (PO) and partial pressure of carbon dioxide (PaCO), were detected; and the differences between the two groups and the possible correlation were analyzed. Compared to the COPD stable group and the control group, the AECOPD group had a statistically significant higher content of plasma FIB and D-dimer (p less than 0.05); the content of plasma FIB and D-dimer of the COPD stable group was much higher than that of the healthy control group, but the difference had no statistical significance (p > 0.05); the content of D-dimer of AECOPD patients was in a negative correlation with FEV1 and PO (p smaller than 0.05) and in a positive correlation with PCO (p smaller than 0.05). It can be concluded that D-dimer is correlated to the severity of AECOPD; hence, it can be used as an evaluation index for the severity of AECOPD.

摘要

本研究旨在观察慢性阻塞性肺疾病急性加重期(AECOPD)患者血浆D-二聚体的变化。将患者分为三组,即AECOPD组、稳定期慢性阻塞性肺疾病组(治疗后病情保持稳定的慢性阻塞性肺疾病组)和健康对照组。检测所有研究对象的血浆纤维蛋白原(FIB)和D-二聚体含量,并分析组间差异。此外,检测AECOPD组和稳定期慢性阻塞性肺疾病组患者的肺功能,包括第1秒用力呼气量(FEV1%)和第1秒用力肺活量率(FEV1/FVC)以及血气(氧分压(PO)和二氧化碳分压(PaCO₂));分析两组之间的差异及可能的相关性。与慢性阻塞性肺疾病稳定组和对照组相比,AECOPD组血浆FIB和D-二聚体含量在统计学上显著更高(p<0.05);慢性阻塞性肺疾病稳定组血浆FIB和D-二聚体含量远高于健康对照组,但差异无统计学意义(p>0.05);AECOPD患者的D-二聚体含量与FEV1和PO呈负相关(p<0.05),与PCO₂呈正相关(p<0.05)。可以得出结论,D-二聚体与AECOPD的严重程度相关;因此,它可作为AECOPD严重程度的评估指标。

相似文献

1
Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期患者血浆D-二聚体变化的检测与研究
J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):839-845.
2
[Change of coagulation functions and its significance in acute exacerbation of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病急性加重期凝血功能的变化及其意义]
Zhonghua Yi Xue Za Zhi. 2011 Jun 14;91(22):1543-5.
3
[Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].慢性阻塞性肺疾病患者C反应蛋白和白细胞介素-18水平、生活质量与肺功能的相关性
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1090-6. doi: 10.3969/j.issn.1672-7347.2011.11.010.
4
[Platelet factor 4 and β-thromboglobulin in blood plasma of patients with acute exacerbation of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病急性加重期患者血浆中的血小板因子4和β-血小板球蛋白]
Zhonghua Yi Xue Za Zhi. 2013 May 14;93(18):1378-82.
5
D-dimer levels in stable COPD patients: a case-control study.稳定期 COPD 患者的 D-二聚体水平:一项病例对照研究。
COPD. 2012 Aug;9(4):426-31. doi: 10.3109/15412555.2012.683840. Epub 2012 May 21.
6
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
Thromb Haemost. 1994 Sep;72(3):343-6.
7
Evaluating the clinical role of fibrinogen, D-dimer, mean platelet volume in patients with acute exacerbation of COPD.评估纤维蛋白原、D-二聚体、平均血小板体积在 COPD 急性加重患者中的临床作用。
Heart Lung. 2023 Jan-Feb;57:54-58. doi: 10.1016/j.hrtlng.2022.08.013. Epub 2022 Aug 31.
8
Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.D-二聚体对慢性阻塞性肺疾病急性加重期患者住院及1年死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2016 Oct 31;11:2729-2736. doi: 10.2147/COPD.S112882. eCollection 2016.
9
D-dimer as a potential biomarker for the progression of COPD.D-二聚体作为慢性阻塞性肺疾病进展的潜在生物标志物。
Clin Chim Acta. 2016 Apr 1;455:55-9. doi: 10.1016/j.cca.2016.01.024. Epub 2016 Jan 28.
10
A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.吸入布地奈德与静脉注射甲泼尼龙治疗慢性阻塞性肺疾病急性加重期的随机对照多中心研究
Respir Med. 2016 Dec;121:39-47. doi: 10.1016/j.rmed.2016.10.013. Epub 2016 Oct 21.

引用本文的文献

1
Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study.纤维蛋白降解产物与慢性阻塞性肺疾病患者生存状况的关系:一项前瞻性观察研究方案
Respir Res. 2023 Jun 27;24(1):172. doi: 10.1186/s12931-023-02472-9.